AGP Executive Report
Last update: 2 hours agoCharity Cycling for Baby Loss in Liechtenstein Region: Two men will ride the EuroVelo 15 Rhine Cycle Route from June 12, camping across Switzerland, Liechtenstein, Austria, Germany, France and the Netherlands to raise funds for Freddie’s Yellow Rose, aiming to build a dedicated bereavement suite at Southmead Hospital. EU Drug Approvals: CinnaGen became the first Iranian pharma firm to win European Commission approval for its osteoporosis medicine Zandoriah (teriparatide). Cancer Care in Europe: The European Commission approved Bristol Myers Squibb’s Opdivo (nivolumab) plus AVD as the first immunotherapy-based regimen in the EU for newly diagnosed advanced classical Hodgkin lymphoma in adults and adolescents (12+). Pet Health Tech in the Region: Fi expanded its AI-powered GPS pet wearables to 38 countries, including coverage for Switzerland, Norway and Liechtenstein, with behavior insights aimed at spotting health changes. Heat and Health Risks: A Europe-wide spring heat wave has shattered temperature records and is linked to multiple deaths, with warnings that more may follow. Local Sports Leadership (Liechtenstein connection): FIS president Johan Eliasch defended commercial-rights centralisation ahead of a June 11 re-election vote, with Liechtenstein’s Alexander Ospelt among candidates.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
